GMO Payment Gateway, Inc.
GMO Payment Gateway, Inc. (GMYTF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for GMO Payment Gateway, Inc. (GMYTF), covering cash flow, earnings, and balance sheets.
GMO Payment Gateway, Inc. (GMYTF) Income Statement & Financial Overview
Explore comprehensive income reports for GMO Payment Gateway, Inc. GMYTF, broken down by year and quarter.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $20.46B | $20.30B | $19.59B | $18.10B |
| Cost of Revenue | $6.54B | $6.68B | $6.82B | $6.03B |
| Gross Profit | $13.92B | $13.62B | $12.77B | $12.06B |
| Gross Profit Ratio | $0.68 | $0.67 | $0.65 | $0.67 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $5.93B | $6.48B | $5.98B | $5.28B |
| Operating Expenses | $5.93B | $6.36B | $7.42B | $5.28B |
| Total Costs & Expenses | $12.47B | $13.04B | $14.24B | $11.31B |
| Interest Income | $178.84M | $356.24M | $267.01M | $273.15M |
| Interest Expense | $135.53M | $107.22M | $313.86M | $40.33M |
| Depreciation & Amortization | $956.02M | $902.67M | $919.44M | $853.61M |
| EBITDA | $9.19B | $8.51B | $6.86B | $7.99B |
| EBITDA Ratio | $0.45 | $0.42 | $0.35 | $0.44 |
| Operating Income | $7.99B | $7.25B | $5.35B | $6.78B |
| Operating Income Ratio | $0.39 | $0.36 | $0.27 | $0.37 |
| Other Income/Expenses (Net) | $115.14M | $249.02M | $271.48M | $315.62M |
| Income Before Tax | $8.10B | $7.50B | $5.62B | $7.10B |
| Income Before Tax Ratio | $0.40 | $0.37 | $0.29 | $0.39 |
| Income Tax Expense | $2.72B | $2.76B | $1.08B | $2.68B |
| Net Income | $5.28B | $4.56B | $4.46B | $5.92B |
| Net Income Ratio | $0.26 | $0.22 | $0.23 | $0.33 |
| EPS | $69.67 | $59.52 | $58.14 | $78.06 |
| Diluted EPS | $68.87 | $59.52 | $57.38 | $77.50 |
| Weighted Avg Shares Outstanding | $75.85M | $76.69M | $75.85M | $75.85M |
| Weighted Avg Shares Outstanding (Diluted) | $76.69M | $76.69M | $77.71M | $76.39M |
Over the last four quarters, GMO Payment Gateway, Inc. achieved steady financial progress, growing revenue from $18.10B in Q3 2024 to $20.46B in Q2 2025. Gross profit stayed firm with margins at 68% in Q2 2025 versus 67% in Q3 2024. Operating income totaled $7.99B in Q2 2025, maintaining a 39% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $9.19B. Net income rose to $5.28B, with EPS at $69.67. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan